Front Range Biosciences inks $8.5 mln

Lafayette, Colorado-based Front Range Biosciences, a technology provider for the breeding and production of new plant varieties and seeds in hemp, coffee and regulated cannabis industries, has secured $8.5 million in funding. The investors included Militello Capital, Welcan Capital, AFI Capital, Phyto Partners, Harvard Business School Alumni Angels of New York, New York Angels, Sand Hill Angels XVI, LLC, Arcadian Capital Management, Halley Venture Partners LP and Salveo Capital.

Source: Press Release